PCSK9 inhibitors and neurocognitive adverse events: exploring the FDA directive and a proposal for N-of-1 trials.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Works matching IS 01145916 AND DT 2015 AND VI 38 AND IP 6
Results: 8
1
2
Methodological approaches to evaluate the impact of FDA drug safety communications.
- Published in:
- 2015
- By:
- Publication type:
- journal article
3
Harmonizing post-market surveillance of prescription drug misuse: a systematic review of observational studies using routinely collected data (2000-2013).
- Published in:
- 2015
- By:
- Publication type:
- journal article
4
Incorporating linked healthcare claims to improve confounding control in a study of in-hospital medication use.
- Published in:
- 2015
- By:
- Publication type:
- journal article
5
Is the yellow card road going in the right direction?
- Published in:
- 2015
- By:
- Publication type:
- Editorial
6
Oral anticoagulants and risk of nephropathy.
- Published in:
- 2015
- By:
- Publication type:
- journal article
7
Comparison of statistical signal detection methods within and across spontaneous reporting databases.
- Published in:
- 2015
- By:
- Publication type:
- journal article
8
Drug-induced renal damage in preterm neonates: state of the art and methods for early detection.
- Published in:
- 2015
- By:
- Publication type:
- journal article